Resection of liver metastases is considered the only treatment with curative potential for patients with metastatic colorectal cancer to the liver (CRLM). However, only a minority of patients with ...

Resection of liver metastases remains the only treatment with curative potential for metastatic colorectal cancer to the liver, but unfortunately few patients are eligible for the surgery. For ...

One treatment-related death occurred in the combination therapy group.

Approximately 25% of patients with colorectal cancer present with metastatic disease to the liver at diagnosis, and about 50% develop liver metastases at some point during the course of the disease.

QUEENSBURY, N.Y.--(BUSINESS WIRE)--Delcath Systems, Inc. (Nasdaq: DCTH), (“Delcath” or the “Company”) an interventional oncology company focused on the treatment of primary and metastatic liver ...

Ipilimumab-nivolumab also linked with better survival but more toxicity in small study ...

The speakers emphasize that symptom burden can alter sequencing priorities and prompt greater integration of supportive ...

Metastatic disease of the liver accounts for the vast majority of detected liver masses. In patients with suspected metastatic disease, cross-sectional imaging with ultrasound (US), computed ...